Albert David Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Albert David Limited Company Profile :

Albert David Limited is an Indian company engaged in manufacturing and trading of pharmaceuticals.

The Company manufactures pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs and disposable syringes and needles in Kolkata, India. The Company operates in the therapeutic segments, such as analgesics anti-inflammatory and anti-bacterials. It also manufactures Sodium stibogluconate, which is used to treat leishmaniasis in Calcutta. Its product Placentrex is derived from the extract of fresh term healthy human placenta. Its product range includes Siocare Range, Verbet, Alamin Range, Actibile and Adliv.

The Company has presence in South East Asia, Africa, countries of Middle East, Europe, the United States and Latin America, covering approximately 35 countries.


Albert David ResultsBSE Code : 524075
NSE Symbol : ALBERTDAVD
ISIN No. : INE155C01010
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Albert David or you are an stock market analyst then i am sure you might for Quarterly Results of Albert David.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Albert David. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Albert David.

Albert David Q1 Results 2016-17 :

Albert David will announce its Q1 FY 2016-17 Results in the month of July 2016.

(Values in Cr.) Q1  Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS  –

Albert David will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2  Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS  –

Albert David will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3  Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS  –

Albert David will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4  Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS  –

Albert David will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 FY 2016-17
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS  –

Note : We will update the results table above as and when results are announced. Visit again.

Albert David Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 322.19
Other Income 1.97
Total Income 324.16
Expenditure -250.33
Interest -1.81
Depreciation -9.00
PBT 63.02
Tax -15.02
Net Profit 48.00
Equity 5.71
EPS 84.10

Note : If you like this information about Albert David Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.